retatrutide trial data just delivered the first top-line Phase 3 results for a triple agonist in obesity — and the findings from TRIUMPH-4 are striking👇 Percent of participants achieving liver

The gastrointestinal tract and brain maintain a crosstalk connection in which gut microbiota and inflammatory response are crucial, and this immune disruption is inextricably related to a neuroinflammatory response mediated by abnormalities in microglia and mitochondrial functions, as well as an increase in oxidative damage

Most commercial plans dont

References Jalleh RJ, Plummer MP, Marathe CS, Umapathysivam MM, Quast DR, Rayner CK, Jones KL, Wu T, Horowitz M, Nauck MA

Once authorization is granted, the members plan copay will apply, according to their benefits

These patient information resources are for clinicians to give to patients